NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
Press Release
Read More
NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
Press Release
Read More
NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors
Press Release
Read More